Robin Jones to Heart Diseases
This is a "connection" page, showing publications Robin Jones has written about Heart Diseases.
Connection Strength
0.801
-
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity. Expert Rev Cardiovasc Ther. 2008 Nov; 6(10):1311-7.
Score: 0.293
-
Anthracycline cardiotoxicity. Expert Opin Drug Saf. 2006 Nov; 5(6):791-809.
Score: 0.255
-
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs. Expert Rev Anticancer Ther. 2006 Sep; 6(9):1249-69.
Score: 0.252